Neoantigen immunopeptidome profiling and production for personalized immuno-oncology therapeutic discovery

Presented by:

Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy. In this webcast, Dr. Raymond Miller of GenScript and Dr. Julie Rumble of Cayman Chemical will review the use of neoantigen peptides in personalized cancer treatment and share techniques for predicting and producing difficult neoantigen peptides.

Speaker-related Webinars

Neoantigen immunopeptidome profiling and production for personalized immuno-oncology therapeutic discovery

Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.

Learn More

Using Predictive Bioinformatics Algorithms for Difficult Neoantigen Peptide Synthesis for Precision Immuno-Oncology Development

Neoantigen based personalized immuno-oncology drugs are a relatively new therpauetic avenue that have shown strong anti-tumor efficacy in the clinic.

Learn More